Among cancer signaling pathways, the phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB or Akt)/mammalian target of rapamycin (mTOR) pathway promotes cellular proliferation and contributes to tumor occurrence and aggravation [148,149]. Here, AKT1 is linked to cancer.